Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ginkgo Bioworks Hldgs Inc (NY: DNA )

6.690 -0.400 (-5.64%)
Official Closing Price Updated: 7:00 PM EDT, Aug 30, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,451,809
Open 7.240
Bid (Size) 6.700 (1)
Ask (Size) 6.840 (6)
Prev. Close 7.090
Today's Range 6.640 - 7.260
52wk Range 0.2100 - 9.330
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
From Promise to Peril: The Downfall of Ginkgo Bioworks
Via Benzinga
Down 88% in 1 Year, What's Next for Ginkgo Bioworks Stock?
Its ambitious business model may not be sustainable. 
Via The Motley Fool

Performance

YTD
+300.60%
+300.60%
1 Month
+1660.53%
+1660.53%
3 Month
+1165.85%
+1165.85%
6 Month
+418.60%
+418.60%
1 Year
+185.90%
+185.90%

More News

Read More
Down 86% This Year, Is Ginkgo Bioworks Stock a Bargain Now?
Via The Motley Fool
Prediction: Artificial Intelligence Will Lead to Higher Returns With Biotech Stocks
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
DNA Stock Earnings: Ginkgo Bioworks Holdings Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
DNA Stock Alert: Ginkgo Bioworks Plunges on Plan for Reverse Stock Split
Via InvestorPlace
7 Meme Mania Stocks: Which Are FOMO and Which Are Free Money?
Via InvestorPlace
7 Sorry Biotech Stocks Set to Make Investors Sad
Via InvestorPlace
AI Demand and New Deals Make Ginkgo Bioworks Stock a Speculative Buy
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
DNA Stock: Ginkgo Bioworks Announces New Collaboration
Via InvestorPlace
Down 81% in 2024, Is Ginkgo Bioworks Stock Still a Buy?
Via The Motley Fool
3 Stocks to Avoid Like the Plague in 2024
Via InvestorPlace
3 High-Risk, Sky-High Reward Stocks to Buy for Under $1
Via InvestorPlace
Stay Away: Why Ginkgo Bioworks Stock Is Not for the Faint-Hearted
Via InvestorPlace
7 F-Rated Stocks To Sell in July
Via InvestorPlace
3 Biotech Stocks to Sell in July Before They Crash & Burn
Via InvestorPlace
Cathie Wood's Ark Invest Dumps Another $3.25M Worth Of Tesla Shares Amid Searing Q2 Deliveries Rally
Via Benzinga
Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
Via InvestorPlace
Cathie Wood's Ark Invest Acquires $7.3M Worth Of Shares In This Promising Netflix Competitor, Sells Off Coinbase Stock Amid Bitcoin Slump
Via Benzinga
Perion Layoffs 2024: What to Know About the Latest PERI Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Ginkgo Bioworks Layoffs Expand to 400 Job Cuts
Via InvestorPlace
Topics Workforce
Exposures Layoff
Why Ginkgo Bioworks Stock Is Sinking Today
Via The Motley Fool
Cathie Wood-Led Ark Invest Dumps $4.3M Worth Of Nvidia Shares Amid Rebound — Swoops Into Buy Stock Of This Netflix Rival
Via Benzinga
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
Via Benzinga
Coffee Recall 2024: Over 250 Coffee Products Recalled Due to Botulism Fears
Via InvestorPlace
Exposures Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.